Dfpg Investments LLC Has $3.53 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Posted by Defense World Staff on Jun 22nd, 2023

Dfpg Investments LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 36.5% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,464 shares of the healthcare conglomerate’s stock after buying an additional 1,994 shares during the quarter. Dfpg Investments LLC’s holdings in UnitedHealth Group were worth $3,527,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. MFA Wealth Advisors LLC grew its position in UnitedHealth Group by 4.8% in the third quarter. MFA Wealth Advisors LLC now owns 414 shares of the healthcare conglomerate’s stock valued at $209,000 after purchasing an additional 19 shares in the last quarter. Formidable Asset Management LLC boosted its position in UnitedHealth Group by 1.5% during the third quarter. Formidable Asset Management LLC now owns 1,366 shares of the healthcare conglomerate’s stock valued at $741,000 after purchasing an additional 20 shares during the last quarter. McElhenny Sheffield Capital Management LLC increased its position in shares of UnitedHealth Group by 1.6% during the 4th quarter. McElhenny Sheffield Capital Management LLC now owns 1,317 shares of the healthcare conglomerate’s stock worth $698,000 after purchasing an additional 21 shares during the last quarter. First Bank & Trust boosted its holdings in shares of UnitedHealth Group by 1.9% in the 4th quarter. First Bank & Trust now owns 1,115 shares of the healthcare conglomerate’s stock valued at $591,000 after buying an additional 21 shares during the last quarter. Finally, Triumph Capital Management increased its holdings in UnitedHealth Group by 3.5% during the fourth quarter. Triumph Capital Management now owns 616 shares of the healthcare conglomerate’s stock worth $327,000 after buying an additional 21 shares during the last quarter. Institutional investors and hedge funds own 92.61% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,008 shares of the business’s stock in a transaction that occurred on Friday, April 21st. The shares were sold at an average price of $484.58, for a total transaction of $488,456.64. Following the sale, the executive vice president now directly owns 10,359 shares of the company’s stock, valued at approximately $5,019,764.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,008 shares of the company’s stock in a transaction dated Friday, April 21st. The stock was sold at an average price of $484.58, for a total value of $488,456.64. Following the sale, the executive vice president now owns 10,359 shares in the company, valued at approximately $5,019,764.22. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Andrew Witty sold 6,160 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total value of $3,002,938.40. Following the completion of the transaction, the chief executive officer now directly owns 86,564 shares in the company, valued at $42,199,084.36. The disclosure for this sale can be found here. Over the last three months, insiders have sold 8,852 shares of company stock worth $4,313,962. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Trading Up 1.6 %

Shares of UNH opened at $476.76 on Thursday. The business’s fifty day moving average is $486.82 and its 200-day moving average is $493.14. The firm has a market cap of $443.88 billion, a price-to-earnings ratio of 21.80, a PEG ratio of 1.34 and a beta of 0.68. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.81 and a current ratio of 0.81. UnitedHealth Group Incorporated has a 52-week low of $445.68 and a 52-week high of $558.10.

UnitedHealth Group (NYSE:UNH – Get Rating) last posted its quarterly earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share for the quarter, beating analysts’ consensus estimates of $6.24 by $0.02. UnitedHealth Group had a net margin of 6.16% and a return on equity of 27.05%. The company had revenue of $91.93 billion for the quarter, compared to the consensus estimate of $89.77 billion. During the same period last year, the company posted $5.49 EPS. The firm’s quarterly revenue was up 14.7% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Incorporated will post 24.86 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 27th. Shareholders of record on Monday, June 19th will be given a $1.88 dividend. The ex-dividend date of this dividend is Thursday, June 15th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.65. This represents a $7.52 annualized dividend and a yield of 1.58%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.39%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on UNH. Stephens reaffirmed an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a report on Tuesday, February 28th. SVB Securities reduced their target price on UnitedHealth Group from $625.00 to $560.00 in a research note on Wednesday, June 14th. Piper Sandler started coverage on UnitedHealth Group in a report on Thursday, May 25th. They set an “overweight” rating and a $580.00 price target for the company. Loop Capital increased their price objective on shares of UnitedHealth Group from $590.00 to $600.00 and gave the company a “buy” rating in a research report on Monday, April 17th. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on shares of UnitedHealth Group from $627.00 to $564.00 in a research report on Friday, June 16th. One investment analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and an average price target of $592.68.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.